ARRY
Price
$6.32
Change
-$0.18 (-2.77%)
Updated
Jun 27, 12:49 PM (EDT)
Capitalization
2.22B
46 days until earnings call
MCRB
Price
$9.14
Change
-$0.37 (-3.89%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
83.05M
39 days until earnings call
Interact to see
Advertisement

ARRY vs MCRB

Header iconARRY vs MCRB Comparison
Open Charts ARRY vs MCRBBanner chart's image
Array Technologies
Price$6.32
Change-$0.18 (-2.77%)
Volume$2K
Capitalization2.22B
Seres Therapeutics
Price$9.14
Change-$0.37 (-3.89%)
Volume$265
Capitalization83.05M
ARRY vs MCRB Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. MCRB commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Buy and MCRB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (MCRB: $9.51)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 1 FA rating(s) are green while.

  • MCRB’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 6 TA indicator(s) are bullish while MCRB’s TA Score has 4 bullish TA indicator(s).

  • ARRY’s TA Score: 6 bullish, 3 bearish.
  • MCRB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than MCRB.

Price Growth

MCRB (@Biotechnology) experienced а +23.03% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

MCRB is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($2.22B) has a higher market cap than MCRB($83M). ARRY YTD gains are higher at: 7.616 vs. MCRB (-42.780). ARRY has higher annual earnings (EBITDA): 276M vs. MCRB (-55.82M). ARRY has more cash in the bank: 249M vs. MCRB (58.8M). MCRB has less debt than ARRY: MCRB (89.5M) vs ARRY (730M). ARRY has higher revenues than MCRB: ARRY (1.58B) vs MCRB (0).
ARRYMCRBARRY / MCRB
Capitalization2.22B83M2,677%
EBITDA276M-55.82M-494%
Gain YTD7.616-42.780-18%
P/E Ratio26.23N/A-
Revenue1.58B0-
Total Cash249M58.8M423%
Total Debt730M89.5M816%
FUNDAMENTALS RATINGS
ARRY vs MCRB: Fundamental Ratings
ARRY
MCRB
OUTLOOK RATING
1..100
5514
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6064
P/E GROWTH RATING
1..100
28100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCRB's Valuation (25) in the Biotechnology industry is significantly better than the same rating for ARRY (99). This means that MCRB’s stock grew significantly faster than ARRY’s over the last 12 months.

MCRB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that MCRB’s stock grew similarly to ARRY’s over the last 12 months.

MCRB's SMR Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that MCRB’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's Price Growth Rating (60) in the Biotechnology industry is in the same range as MCRB (64). This means that ARRY’s stock grew similarly to MCRB’s over the last 12 months.

ARRY's P/E Growth Rating (28) in the Biotechnology industry is significantly better than the same rating for MCRB (100). This means that ARRY’s stock grew significantly faster than MCRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYMCRB
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 17 days ago
80%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIRBX75.920.53
+0.70%
American Funds Capital Income Bldr R2
MDFGX38.66N/A
N/A
BlackRock Capital Appreciation Inv A
CCCNX6.68N/A
N/A
Center Coast Brookfield Midstream Foc I
TBDQX20.13N/A
N/A
PGIM Jennison Diversified Growth R6
HIAHX15.45N/A
N/A
Hartford Healthcare HLS IA

ARRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARRY has been closely correlated with SHLS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARRY jumps, then SHLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
+4.17%
SHLS - ARRY
66%
Closely correlated
+0.21%
FSLR - ARRY
61%
Loosely correlated
+1.92%
NXT - ARRY
59%
Loosely correlated
+1.77%
RUN - ARRY
57%
Loosely correlated
+6.46%
AXON - ARRY
53%
Loosely correlated
+2.40%
More